ARCHIVES

Drugs and Targets: FDA extends Lymphoseek label to include mapping in solid tumors

This article is from The Cancer Letter archive.

Vol. 40 No. 41 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

NPCC Workshop Developed “Exciting List” Of Projects, Organizer Says

November 8, 1996

FDA Clears Rapid Test For Aspergillus Infection

May 30, 2003

Group Urges U.S., USSR Exchange In Surgical Oncology

January 6, 1989

In Brief: Jane Henney Sworn In As FDA Commissioner; Six Centers Retain Comprehensive Status

December 18, 1998

Cancer Centers Branch To Be ‘More Proactive,’ Kimes Tells NCAB

January 5, 1990

Combine Phase 1-2, Abolish DRG, Slash Indirect Costs, Garb Tells Congress

November 27, 1981